BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15502220)

  • 1. Methods for detecting somatic mutations in vitro: the human T-cell cloning assay selecting for HPRT mutants.
    Hou SM
    Methods Mol Biol; 2005; 291():155-60. PubMed ID: 15502220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human T-cell cloning assay: identifying genotypes susceptible to drug toxicity and somatic mutation.
    Hou SM
    Methods Mol Biol; 2014; 1105():283-9. PubMed ID: 24623236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrogen peroxide induced mutations at the HPRT locus in primary human T-lymphocytes.
    Díaz-Llera S; Podlutsky A; Osterholm AM; Hou SM; Lambert B
    Mutat Res; 2000 Aug; 469(1):51-61. PubMed ID: 10946242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mouse model for the study of in vivo mutational spectra: sequence specificity of ethylene oxide at the hprt locus.
    Walker VE; Skopek TR
    Mutat Res; 1993 Jul; 288(1):151-62. PubMed ID: 7686258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenicity of 1,3-butadiene at the Hprt locus of T-lymphocytes following inhalation exposures of female mice and rats.
    Meng Q; Henderson RF; Chen T; Heflich RH; Walker DM; Bauer MJ; Reilly AA; Walker VE
    Mutat Res; 1999 Aug; 429(1):107-25. PubMed ID: 10434027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational spectra at the hypoxanthine-guanine phosphoribosyltransferase (HPRT) locus in T-lymphocytes of nonsmoking and smoking lung cancer patients.
    Hackman P; Hou SM; Nyberg F; Pershagen G; Lambert B
    Mutat Res; 2000 Jun; 468(1):45-61. PubMed ID: 10863157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPRT mutations in humans: biomarkers for mechanistic studies.
    Albertini RJ
    Mutat Res; 2001 Oct; 489(1):1-16. PubMed ID: 11673087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and spectrum of ethylnitrosourea-induced mutation at the hprt and lacI loci in splenic lymphocytes of exposed lacI transgenic mice.
    Walker VE; Gorelick NJ; Andrews JL; Craft TR; deBoer JG; Glickman BW; Skopek TR
    Cancer Res; 1996 Oct; 56(20):4654-61. PubMed ID: 8840980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational spectrum at the Hprt locus in splenic T cells of B6C3F1 mice exposed to N-ethyl-N-nitrosourea.
    Skopek TR; Walker VE; Cochrane JE; Craft TR; Cariello NF
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):7866-70. PubMed ID: 1518807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro induction, expression and selection of thioguanine-resistant mutants with human T-lymphocytes.
    O'Neill JP; Sullivan LM; Albertini RJ
    Mutat Res; 1990 Feb; 240(2):135-42. PubMed ID: 2300074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of point mutations in the coding region of the hypoxanthine-guanine phosphoribosyltransferase (hprt) gene in human T-lymphocytes in vivo.
    Podlutsky A; Osterholm AM; Hou SM; Hofmaier A; Lambert B
    Carcinogenesis; 1998 Apr; 19(4):557-66. PubMed ID: 9600338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HPRT mutant T-cell assays for human mutagenicity monitoring.
    Albertini RJ; Nicklas JA; O'Neill JP
    Prog Clin Biol Res; 1986; 209B():185-94. PubMed ID: 3489238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new T-lymphocyte cloning assay for detection of in vivo mutations in the human hypoxanthine-guanine phosphoribosyltransferase gene.
    Uematsu K; Yasuda J; Sekine T; Sugano K; Kudoh S; Sekiya T
    Environ Mol Mutagen; 1997; 30(1):31-9. PubMed ID: 9258327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo mutagenicity of ethylene oxide at the hprt locus in T-lymphocytes of B6C3F1 lacI transgenic mice following inhalation exposure.
    Walker VE; Sisk SC; Upton PB; Wong BA; Recio L
    Mutat Res; 1997 Aug; 392(3):211-22. PubMed ID: 9294020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of the hprt gene in human in vivo-derived 6-thioguanine-resistant T lymphocytes.
    Albertini RJ; O'Neill JP; Nicklas JA; Heintz NH; Kelleher PC
    Nature; 1985 Jul 25-31; 316(6026):369-71. PubMed ID: 2991767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel types of mutation identified at the hprt locus of human T-lymphocytes.
    Hou SM
    Mutat Res; 1994 Jul; 308(1):23-31. PubMed ID: 7516483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylglyoxal induces hprt mutation and DNA adducts in human T-lymphocytes in vitro.
    Hou SM; Nori P; Fang JL; Vaca CE
    Environ Mol Mutagen; 1995; 26(4):286-91. PubMed ID: 8575417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of styrene oxide-induced hprt mutation in human T-lymphocytes.
    Bastlová T; Podlutsky A
    Mutagenesis; 1996 Nov; 11(6):581-91. PubMed ID: 8962428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of in vivo mutation assays: analysis of hprt, lacI, cII/cI and as mutational targets for N-nitroso-N-methylurea and benzo[a]pyrene in Big Blue mice.
    Monroe JJ; Kort KL; Miller JE; Marino DR; Skopek TR
    Mutat Res; 1998 Oct; 421(1):121-36. PubMed ID: 9748534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the human T-lymphocyte cloning assay--ring test report from the EU concerted action on HPRT mutation (EUCAHM).
    Hou SM; Van Dam FJ; de Zwart F; Warnock C; Mognato M; Turner J; Podlutskaja N; Podlutsky A; Becker R; Barnett Y; Barnett CR; Celotti L; Davies M; Hüttner E; Lambert B; Tates AD
    Mutat Res; 1999 Dec; 431(2):211-21. PubMed ID: 10635988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.